Common Contracts

AMENDMENT NO. 1 TO ARRANGEMENT AGREEMENT

Arrangement Agreement • November 19th, 2007 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Ontario

• Contract Type
  Arrangement Agreement
• Filed
  November 19th, 2007
• Company
  Lorus Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Ontario

This AMENDMENT NO. 1 TO ARRANGEMENT AGREEMENT is made as of May 14, 2007 (“Amending Agreement”) by and between Lorus Therapeutics Inc. (“Old Lorus”), NuChem Pharmaceuticals Inc. (“NuChem”), GeneSense Technologies Inc. (“GeneSense”), 6650309 Canada Inc. (“New Lorus”), Pinnacle International Lands, Inc. (“Pinnacle”), and 6707157 Canada Inc. (“Investor”).

AMENDMENT NO. 2 TO ARRANGEMENT AGREEMENT AND AMENDMENT TO PLAN OF ARRANGEMENT

Arrangement Agreement • July 10th, 2007 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Ontario

• Contract Type
  Arrangement Agreement
• Filed
  July 10th, 2007
• Company
  Lorus Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Ontario

This AMENDMENT NO. 2 TO ARRANGEMENT AGREEMENT and AMENDMENT TO PLAN OF ARRANGEMENT is made as of July 4, 2007 (“Amending Agreement”) by and between Lorus Therapeutics Inc. (“Old Lorus”), NuChem Pharmaceuticals Inc. (“NuChem”), GeneSense Technologies Inc. (“GeneSense”), 6650309 Canada Inc. (“New Lorus”), Pinnacle International Lands, Inc. (“Pinnacle”), and 6707157 Canada Inc. (“Investor”).